Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience

• Luigi Gargiulo,
• Luciano Ibba,
• Carlo A. Vignoli,
• Silvia M. Ferrucci,
• Santo R. Mercuri,
• Piergiorgio Malagoli,
• Angelo V. Marzano,
• Mauro Barbareschi,
• Vittoria G. Bianchi,
• Mario Valenti,
• Antonio Costanzo,
• Alessandra Narcisi

Affiliations

Luigi Gargiulo

Dermatology Unit, IRCCS Humanitas Research Hospital

Luciano Ibba

Dermatology Unit, IRCCS Humanitas Research Hospital

Carlo A. Vignoli

Dermatology Unit, IRCCS Humanitas Research Hospital

Silvia M. Ferrucci

Dermatology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico

Santo R. Mercuri

Dermatology and Cosmetology Unit, IRCCS San Raffaele Hospital

Piergiorgio Malagoli

Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese

Angelo V. Marzano

Dermatology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico

Mauro Barbareschi

Department of Pathophysiology and Transplantation, Università degli Studi di Milano

Vittoria G. Bianchi

Dermatology and Cosmetology Unit, IRCCS San Raffaele Hospital

Mario Valenti

Dermatology Unit, IRCCS Humanitas Research Hospital

Antonio Costanzo

Dermatology Unit, IRCCS Humanitas Research Hospital

Alessandra Narcisi

Dermatology Unit, IRCCS Humanitas Research Hospital